Empowering Excellence In Pharmaceuticals
SLPMA is an organization of private pharmaceutical companies that have been manufacturing high-quality essential medicines locally for over 60 years. Our members supply pharmaceuticals to government hospitals, as well as to local and international markets.
R&D Support
We provide R&D Support for Sri Lanka's Pharmaceutical Future
A Global Vision
We aim to position Sri Lanka as a key player in the international market
SLPMA Is Dedicated To:
Driving Efficiency in Sri Lankan Pharmaceuticals
Elevating local production standards and strengthening our presence in the global market.
Championing Health and Well-Being
Aligning success with a global mission to enhance healthcare access and quality across Sri Lanka.
Innovating Through Research and Development
Actively promoting new medicines for both communicable and non-communicable diseases.
Building a Globally Competitive Industry
Establishing a pharmaceutical industry that meets international standards and contributes to economic growth.
Shaping Sri Lanka's Health and Development Future
Contributing to both the economic and healthcare future of Sri Lanka.
Upholding Excellence in Compliance and Quality
Committed to maintaining stringent regulatory and quality standards in the pharmaceutical sector.
Want To Become A Member ?Team Member
Shape the Future Together: Join us today to make your voice heard and benefit from the collective knowledge and support of our members
Fostering Economic Growth Through Global Pharmaceutical Excellence
We are committed to building an internationally competitive pharmaceutical industry that reduces imports and boosts foreign exchange for Sri Lanka.
Be Part Of A Vibrant Community
Dedicated To Advancing The
Pharmaceutical Industry In Sri Lanka.
apply now and take the first step towards a
rewarding partnership!
Please reach out to us through the contact form below, and we'll get back to you as soon as possible.
See Our Latest
Blog Posts
SLPMA seeks national push to make pharma next export engine
SLPMA called for a national policy push to transform pharmaceutical manufacturing into one of the country’s next major export industries.
Read More
Sri Lanka pharma sets sights on US$ 1.8tn global market
Sri Lanka’s pharmaceutical manufacturing industry is pushing to evolve from an import-substitution model into a multi-billion dollar export engine, eyeing the US$ 1.8 trillion global market.
Read More
SL pharma manufacturers has potential to tap USD 1.8 Tn global industry -SLPMA
Sri Lanka pharmaceutical manufacturers have the potential to tap the global pharmaceutical industry worth USD 1.8 trillion, SLPMA President Dinesh Athapaththu told the 60th AGM.
Read More
Sri Lanka can be a hub for pharmaceutical manufacturing
Sri Lanka can be a hub for pharmaceutical manufacturing in the region, if it could improve on quality and delivery of products, according to industry experts.
Read More
The National Medicines Regulatory Authority Act, No. 05 of 2015 Registration and Licensing of Medicines (Fees) Regulations -2025
The National Medicines Regulatory Authority Act, No. 05 of 2015 Registration and Licensing of Medicines (Fees) Regulations - 2025 published under Gazette No. 2452/39.
Read More
Pharma industry calls to extend buy back agreement
SLPMA calls to extend buy back agreement to 2030, lift VAT on imported packaging material, and enable local manufacturing to grow sharply slashing forex outflow.
Read More
Yaden Laboratories first to export Sri Lankan-made sterile liquid injectables
Yaden Laboratories Ltd. has achieved a significant milestone with its first export of sterile liquid injectables to Zambia in Africa, opening doors to new international opportunities.
Read More
A Proud Moment for Sri Lanka’s Pharmaceutical Industry
The Sri Lanka Pharmaceutical Manufacturers’ Association extends its heartfelt congratulations to Immediate Past President, Mr. Kalana Gamini Hewamallika, Chairman of GammaInterpharm (Pvt) Ltd.
Read More
SLPMA calls for nat’l strategy to produce medicine
The Sri Lanka Pharmaceutical Manufacturers Association (SLPMA) issued a call to action urging all stakeholders within the local pharmaceutical industry to shape a future where Sri Lanka emerges as a trusted, high-quality, and export-driven pharmaceutical manufacturing hub.
Read More
National call to produce medicine in Sri Lanka as strategic priority
The Sri Lanka Pharmaceutical Manufacturers’ Association (SLPMA) issued a powerful national call to action to shape a trusted, export-driven pharmaceutical manufacturing hub.
Read More
Pharma industry warns of collapse without buyback extension
SLPMA warned that domestic pharmaceutical production could collapse from 25% to 5% if vital buyback agreements are not extended.
Read More
National Call to Produce Medicine in Sri Lanka—with Care, Trust, and Unity
On July 11, 2025, SLPMA unveiled the “National Call to Produce Medicine in Sri Lanka—with Care, Trust, and Unity” at its AGM at Galle Face Hotel.
Read More